Table 1.

Patient cohorts

Cohort	ClinicalTrials identifier	N	Cyclophosphamide		Fludarabine		TBI		Disease	T cells
			mg/kg	Days	mg/m2	Days	cGy	Days
120Cy/125Flu	NCT00287131	103	2×60	−7 to −6	5×25	−5 to −1	–		Melanoma	TIL
60Cy/125Flu	NCT03166397	8	2×30	−5 to −4	5×25	−5 to −1	–		Melanoma	TIL
TBI/75Flu	NCT03166397	9	–	–	3×25	−3 to −1	1×200	−4	Melanoma	TIL
30Cy/75Flu	NCT02772198	19	1×~30*	−2	3×25	−4 to −2	–		ALL	CAR-T

*900 mg/m².

ALL, acute lymphocytic leukemia; CAR-T, chimeric antigen receptor T cell; Cy, cyclophosphamide; Flu, fludarabine; TBI, total body irradiation; TIL, tumor-infiltrating T lymphocyte.